ERBB2 and neoplasm: Besides, consistent with the observation of HER2 expression pattern from GSE89377, HER2 expression in stage I (100%, 4/4), II (83%, 5/6), and III (71%, 5/7) showed a downregulation along with the progression of the tumor stage (F = 8.879, P = 0.001).